Even if 'Most Favored Nation' lowers pricing in the US, its impact on total health spending will be insignificant

In the final instalment of a four-part series comparing health systems and financing in Australia and the US, we demonstrate how even a significant reform of medicine pricing in the US will have almost no impact on health spending in that country. …